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I. Constructions of plasmids and strains 
KpnI−PGAL1−BamHI, BamHI−YFP−EcoRI fragments were cloned into pRS402 
backbone upstream of CYC1 transcriptional terminator. The PGAL1 promoter sequence 
corresponds to the 669 base-pair region directly upstream of the start codon of the GAL1 
gene. The KanMX4 and NatMX4 gene deletion cassettes (1, 2) were used to delete 
specific GAL network genes. Integrations were verified by polymerase chain reaction 
(PCR). All strains are diploid and were derived from W303. Complete descriptions of the 
strains used in this study can be found in Table S1. 
 
In Fig. S1 we show an schematic representing the construction of the first-order 
dosage-varied yeast strains. Each rectangle denotes a diploid strain that was dosage-
halved in one of the four regulatory genes of the network.  
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II. Yeast strains used in this study 
Strain Genotype 
MA0491 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal2::KanMX/GAL2 
MA0492 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal3::KanMX/GAL3 
MA0493 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal4::KanMX/GAL4 
MA0494 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal80::KanMX/GAL80 
MA0496 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP  
MA0614 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal2::KanMX/GAL2, GAL3/gal3::KanMX 
MA0615 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal2::KanMX/GAL2, GAL4/gal4::KanMX 
MA0616 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal2::KanMX/GAL2, GAL80/gal80::KanMX 
MA0617 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal3::KanMX/GAL3, GAL4/gal4::KanMX 
MA0618 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal3::KanMX/GAL3, GAL80/gal80::KanMX 
MA0619 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal4::KanMX/GAL4, GAL80/gal80::KanMX 
MA0620 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal2::KanMX/GAL2, gal3::NatMX/GAL3, GAL4/gal4::KanMX 
MA0621 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, gal3::KanMX/GAL3, gal4::NatMX/GAL4, GAL80/gal80::KanMX 
MA0622 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, GAL2/gal2::KanMX, gal3::NatMX/GAL3, gal80::KanMX/GAL80 
MA0623 MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-PGAL1-YFP, GAL2/gal2::KanMX, gal4::KanMX/GAL4, gal80::NatMX/GAL80 
MA0625 
MATa/, leu2/leu2::LEU2, his3::HIS3/his3, ade2::ADE2-PMYO2-rtTA/ade2::ADE2-
PGAL1-YFP, GAL2/gal2::KanMX, gal3::NatMX/GAL3, GAL4/gal4::NatMX, 
gal80::KanMX/GAL80 
 
Table S1. Yeast strains used in this study. 
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III. Growth conditions and media 
Cultures were grown in synthetic dropout media with the appropriate amino-acid 
supplements. During the overnight growth period (20 hours in 30°C shaker), 2% 
raffinose was used as the carbon source. The overnight growth period was followed by 
the induction period (20 hours in 30°C shaker), with cultures containing 0.1% glucose 
and 0-0.4% galactose as carbon sources. 0.1% glucose instead of raffinose was used as 
a background carbon source to ensure a constant growth rate across different galactose 
concentrations. Glucose at this concentration does not fully repress GAL network 
activity. After the induction period, the expression distributions were determined by flow 
cytometry (FACScan; Becton Dickinson). The OD600 values at the end of the induction 
period were kept low (OD600 ≤ 0.322) to prevent nutrient depletion. The culture volume 
was 10ml during both overnight growth and induction periods. 
 
IV. Additional view of the data and quantification of the effect of each gene 
 In Fig. S2, we show another view of the experimental data presented in Fig. 3, 
comparing the inducibility profile of each strain analyzed against that of the wild-type. 
 
 In Fig. 3C, we quantified the average contribution of the second copy of each 
regulatory gene to network inducibility in the following manner. Separately for each 
gene, all genetic backgrounds in which that gene was dosage-halved were identified, 
corresponding to 8 out of 16 strain backgrounds. Inducibility values of the strains that 
carry both copies of a specific gene were subtracted from the inducibility values of the 
strains carrying one copy of that gene in an otherwise identical genetic background and 
these differences were averaged for each gene. To complement Fig. 3C, in Fig. S3 we 
report the average contribution of halving each of the regulatory genes involved using a 
metric based on the average squared differences (denoted 𝜒", fig. S3A) across different 
galactose concentrations and genetic backgrounds. This measure quantifies the average 
contribution of each gene regardless of its sign and it complements the quantification 
based on an average of the differences (denoted Δ) presented in Fig. 3C and fig. S3B.  
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V. Model specification 
We consider an effective stochastic model in which a given promoter site of each 
of the GAL regulated genes (GAL2, GAL3 and GAL80) can be in either a state of active 
transcription (ON-state) or in a state in which transcription occurs less often (OFF-state) 
(3, 4). Each of these states is characterized by its typical transcription rate. We chose to 
parameterize the system so that one copy of the GALi gene will produce the 
corresponding proteins at rate 𝜃%  (which coarse-grains the processes of transcription, 
translation and protein folding) when in the ON-state and at rate 𝜆𝜃%, when in the OFF-
state. So 𝜆 represents the relative transcriptional strength of the OFF-state compared to 
the ON-state. 
We consider that slow stochastic transitions between these transcriptional states 
are possible and that the total concentration of the different regulatory proteins affects 
the rate at which the OFF → ON transition takes place. 
OFF        ℎ 𝜌(𝑥", 𝑥1, 𝑥2, 𝑥34)ℎ        ON (1)  
In this scheme the parameter ℎ represents a typical timescale at which these transitions 
take place and 𝜌 is a function that quantifies how the total concentrations of the different 
GAL proteins (𝑥", 𝑥1, 𝑥2, 𝑥34) affect the OFF → ON transition. This description is valid as 
long as the molecular interactions that shape the regulating function 𝜌 occur much more 
rapidly than the typical timescale at which protein concentrations change due to the 
processes of transcription, translation, and protein dilution/degradation. 
We parameterized 𝜌 by taking into account what is known about the way the 
different GAL proteins interact with each other and affect transcription. In Fig. S4 we 
represent schematically the main interactions between the proteins involved.  
First, it is known that the GAL4 protein is the main transcriptional activator when 
it is not bound by GAL80 proteins, so we proposed the form  
𝜌 = 7𝑥2∗𝐾2:; (2)  
where 𝐾2 represents the effective typical concentration scale of the interaction, 𝜂 > 0 is 
its typical effective nonlinearity, and 𝑥2∗ is the concentration of GAL4 that is not bound by 
GAL80 and can therefore freely activate transcription. Instead of writing a set of 
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reactions for describing how 𝑥2∗ depends on the total concentrations of the GAL network 
proteins, we propose to use simple functional forms that effectively describe the main 
nature of the interactions. In these functional forms, the molecular interactions are 
characterized by typical concentration scales of action for each protein and by typical 
degrees of nonlinearity quantified by positive exponents. In this case, we know that the 
amount of free GAL4 proteins will be a decreasing function of the concentration of 
GAL80 proteins in the nucleus and an increasing function of the total concentration of 
GAL4 proteins. Therefore, we propose to use the form 𝑥2∗ = 𝑥21 + ABCD∗ECDFG (3)  
where 𝑥34∗  is the concentration of GAL80 proteins in the nucleus. This quantity, in turn, is 
regulated by the active GAL3 proteins due to sequestration 𝑥34∗ = 𝑥341 + ABH∗EHFI (4)  
where 𝑥1∗  is the concentration of active GAL3 proteins. The internal galactose 
concentration, 𝑔∗, regulates the activation of GAL3 proteins and therefore we propose to 
write 𝑥1∗ = 𝑥11 + AK∗ELFMN. (5)  
Note that in this case the number of active GAL3 proteins is an increasing function of the 
concentration of internal galactose because we assume 𝜈 > 0. Finally, the concentration 
of internal galactose is regulated by the concentration of galactose with which the cells 
were grown, 𝑔, and the amount of GAL2 proteins (the galactose permease) and so we 
write  𝑔∗ = 𝑔1 + ABQEQFMR. (6)  
Equations (2) to (6) describe how the rate of the OFF → ON transition is regulated 
by the total concentrations of the different proteins involved as well as the concentration 
of external galactose.  
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To finalize the specification of the model, we also assumed that the protein 
degradation rates were slow compared to the growth rate and so we only included the 
effect of the dilution of proteins at rate 𝛾 , the average growth rate of yeast in the 
laboratory. 
We simulated this system by using a custom-written C++ implementation of the 
Gillespie algorithm, which considered the production of proteins, their dilution due to cell 
growth, and the transitions between the transcriptional states as first-order stochastic 
reactions. In Fig. S5 we show sample trajectories for the different variables in a 
simulation corresponding to the parameters reported in Sections VI and VIII. 
 
VI. Constraints on model parameters 
 To keep our model realistic, we constrained the values of several parameters to 
previously measured quantities. However, some quantities (especially the effective 
parameters we used) were difficult to estimate based on published work and therefore 
we extracted them out by fitting the model to our data. 
 On one hand, the doubling time of yeast in the environments used in this study is 
about 90 minutes, which imposes the constraint 𝛾 ≈ 0.46 h-1. 
 Previous high-throughput studies identified fold-differences in transcript levels for 
several yeast genes under two different growth conditions. More specifically, yeast cells 
were grown in two separate environments, one promoting the expression of the GAL 
genes and one repressing it. Average differences of about 5.5-fold and 3.7-fold were 
reported for GAL3 and GAL80, respectively (5). A high-throughput study that quantified 
the amount and localization of different yeast proteins reported that there were about 
800 GAL3 and 700 GAL80 proteins per cell when the GAL genes were repressed (6), 
which in the context of the proposed model would correspond to the situation in which 
these genes are in the OFF transcriptional state. Considering these observations and 
with the aim of simplifying the description further, we assumed that all GAL-regulated 
genes in the network follow a similar regulation scheme and fixed the values of the 
parameters 𝜃1, 𝜃34 and 𝜆 to obtain basal expression levels of about 750 proteins per cell 
and a 5-fold increase in protein levels when the network is fully induced. So, taking the 
dilution rate into account, this implies the constraints 𝜃1 ≅ 𝜃34 ≅ 1725 proteins/h and 𝜆 ≅ 0.2. Related experimental evidence for GAL2 is more elusive and for the sake of 
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simplicity we assumed the same transcription rate as for GAL3 and GAL80. The same 
studies also reported that the level of GAL4 transcripts does not change significantly 
between galactose-free and galactose-rich media (5) and that GAL4 proteins are present 
at a concentration of about 200 proteins per cell (6), which implies the constraint 𝜃2 ≅ 92 
proteins/h. 
 We note that in the model at hand the stochasticity in the change of the 
transcriptional plan is described by slow transitions between two different states. In this 
framework, the fluctuations in protein expression levels play a secondary role in 
establishing the fraction of active cells under a given condition, though they still play a 
major role in shaping the distributions associated with OFF and ON expression states. 
Furthermore, the way we set up the regulation scheme indicated by equations (2)-(6) 
allows us to interpret the constants 𝐾%  as being expressed in terms of the typical 
concentrations of the associated proteins. Therefore, we don’t  lose generality by using 
parameter values 𝜃% that might deviate slightly from experimental measurements. 
 The values of the parameters used in simulations and fits presented in this study 
can be found in Table S2. These parameters were constrained with respect to the 
previous studies described in this section. 
Parameter Value 𝜃" 1500 proteins/h 𝜃1 1500 proteins/h 𝜃2 100 proteins/h 𝜃34 1500 proteins/h 𝜆 0.2 𝛾 0.46 h-1 
 
Table S2. Parameters fixed based on previous observations. 
 In order to obtain OFF and ON expression states that are well-separated from 
each other, the time that it takes for protein levels to equilibrate has to be shorter than 
the typical timescale of the transitions between the two transcriptional states. We 
quantified the timescale of transitions through the parameter ℎ in equation (1). Exploring 
a range of values for this quantity, we found reasonable agreement with the 
experimental results for ℎ = 2.5 h-1 (Fig. S5 and Fig. S6A-C). If the value of ℎ is too high 
(Fig. S6C) the distribution of protein numbers becomes monomodal; on the other hand if 
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this parameter is too low (Fig. S6A), the dynamics of establishment of fractions would be 
too slow compared to the experimental observations and in the case of multiple 
promoters it would lead to the appearance of three distinct expression states, which is 
something that is not observed experimentally. We also note that all inferences 
presented in this work are based on the analytical approximation described in the next 
section, where the exact value of the parameter ℎ becomes immaterial. 
 
VII. Analytical approximation 
 The stochastic simulation of the model described above is computationally time 
consuming. To simplify the exploration of model parameters and/or alternative models, 
we developed an approximation for the steady-state fraction of actively transcribing cells 
in a macroscopic population. We note that the presentation of the approximation 
proposed here is not a rigorous derivation. We based it on intuition and heuristic 
observations, and we eventually confirmed its power by comparing inferences drawn 
from it to those obtained from detailed stochastic simulations (Fig. S6D). 
 For one cell, we can approximate the time-evolution of the number of proteins 
associated with each GAL-network-regulated gene with a set of Langevin equations 
(7-9) of the form 𝑥V̇ = 𝜃%[𝜙 + 𝜆(1 − 𝜙)] − 𝛾𝑥% + 𝜉% (7)  
where 𝑥% represents the concentration of the protein associated with the GALi gene, 𝜙 is 
a random binary variable that indicates whether the cell is transcribing or not, and 𝜉% is a 
random variable that approximates the intrinsic stochasticity associated with the 
processes of protein production and dilution. 
 An equation for the evolution of mean protein numbers across a population of 
cells, 〈𝑥%〉, can be obtained by averaging equation (7) above. If we assume that the 
intrinsic noise in protein expression can be neglected we obtain a set of equations of the 
form: 𝑥V̇ = 𝜃%[𝜆 + (1 − 𝜆)〈𝜙〉] − 𝛾〈𝑥%〉 (8)  
where 〈𝜙〉  represents the fraction of cells that are actively transcribing. Following a 
mean-field approximation approach, we estimate the fraction 〈𝜙〉 with the value that we 
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would infer from assuming a constant background of protein concentrations equal to 
their average values, namely: 
〈𝜙〉 ≅ 〈 𝑘OFF→ON(𝑥", 𝑥1, 𝑥2, 𝑥34)𝑘OFF→ON(𝑥", 𝑥1, 𝑥2, 𝑥34) + 𝑘ON→OFF〉 ≅ 11 + 𝑘ON→OFF𝑘OFF→ON(〈𝑥"〉, 〈𝑥1〉, 〈𝑥2〉, 〈𝑥34〉)= 11 + [𝜌(〈𝑥"〉, 〈𝑥1〉, 〈𝑥2〉, 〈𝑥34〉)]M` ≡ 𝑓(〈𝑥"〉, 〈𝑥1〉, 〈𝑥2〉, 〈𝑥34〉) 
(9)  
where we have explicitly incorporated the parameterization proposed in equation (1) and 
where we have assumed that the different copies of each promoter act in a correlated 
way due to the effect of the different proteins involved. 
 Taking into account that GAL4 is not subject to regulation, the argument above 
implies that the dynamics of the system can be approximated by the system 
⎩⎨
⎧ 𝑥"̇ = 𝜃"[𝜆 + (1 − 𝜆)𝑓(𝑥", 𝑥1, 𝑥2, 𝑥34)] − 𝛾𝑥"𝑥1̇ = 𝜃1[𝜆 + (1 − 𝜆)𝑓(𝑥", 𝑥1, 𝑥2, 𝑥34)] − 𝛾𝑥1𝑥2̇ = 𝜃2 − 𝛾𝑥2𝑥34̇ = 𝜃34[𝜆 + (1 − 𝜆)𝑓(𝑥", 𝑥1, 𝑥2, 𝑥34)] − 𝛾𝑥34f (10)  
where we have dropped the angled brackets to simplify notation. 
In steady state, in order to obtain a self-consistent solution, the following set of 
algebraic equations must be satisfied: 
⎩⎨
⎧0 = 𝜃"[𝜆 + (1 − 𝜆)𝑓(𝑥", 𝑥1, 𝑥2, 𝑥34)] − 𝛾𝑥"0 = 𝜃1[𝜆 + (1 − 𝜆)𝑓(𝑥", 𝑥1, 𝑥2, 𝑥34)] − 𝛾𝑥10 = 𝜃2 − 𝛾𝑥20 = 𝜃34[𝜆 + (1 − 𝜆)𝑓(𝑥", 𝑥1, 𝑥2, 𝑥34)] − 𝛾𝑥34f (11)  
We note that these equations imply that in equilibrium the concentrations of GAL2, 
GAL3, and GAL80 will be proportional to each other through their relative transcriptional 
strengths, 𝑥"𝜃" = 𝑥1𝜃1 = 𝑥34𝜃34, (12)  
which allows us to reduce this set of relations to just one equation: 0 = 𝜃1 g𝜆 + (1 − 𝜆)𝑓 AhQhH𝑥1, 𝑥1, hij , hCDhH 𝑥1Fk − 𝛾𝑥1. (13)  
Solving this equation for 𝑥1 and then computing 𝑓 AlQlH𝑥1, 𝑥1, lim , lCDlH 𝑥1F allows us to obtain 
an approximation for the fraction of actively transcribing cells in a given population. We 
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solved this equation by bisection search considering as extrema the minimum and 
maximum possible GAL3 concentrations that can be achieved under this scheme (𝜆𝜃1/𝛾 
and 𝜃1/𝛾 respectively).  
 In Fig. S6D, we compare the results obtained from detailed simulations of the 
stochastic process specified in Section V to the analytical approximation proposed in this 
section for a range of galactose values that includes those used in the experiments 
presented in this article. We observe reasonable agreement, which supports the 
usefulness of the approximation proposed as a proxy for studying the behavior of the 
system in a manner that is less taxing from the computational point of view. 
 
VIII. Fitting procedure and best fit results 
We determined the set of parameters that best describes the data by confronting 
the measurements with the model predictions using a Bayesian inference approach (10). 
Briefly, we assumed that for a given set of parameters, the likelihood of observing each 
measurement follows a normal distribution centered on the value indicated by the model 
and with an estimated uncertainty of 10% which is representative of the repeatability of 
the experiments. Applying Bayes theorem, this defines a distribution over parameter 
space where each parameter set gets weighed according to its likelihood of representing 
the data. We sampled this distribution using a Metropolis-Hastings algorithm, which 
allowed us to obtain estimates of the parameter set that has the highest likelihood of 
being a good description of the data as well as the corresponding uncertainties. 
The sampling algorithm was run by following 10 independent Markov chains 
starting from the point indicated in Table S3. For each parameter, normal distributions 
with widths as indicated in the same table and centered in the previous point were used 
as jump distributions. We also imposed lower and upper bounds as indicated but the 
chains stayed away from the boundaries except in the case of  𝐾", which we relate to the fact that the experimental system does not exhibit much 
sensitivity to changes in the dosage of GAL2 in the conditions explored. Each chain was 
followed for 10000 iterations and only the second half of the simulations was used to 
draw inferences. 
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Parameter Sampling parameters 
symbol Unit starting point Jump width lower bound upper bound 𝐾" proteins 1000 200 0.1 4000 𝐾K proteins 0.03 0.01 0.002 1 𝐾1 proteins 2.0 0.5 0.1 10 𝐾34 proteins 8.0 0.5 0.3 200 𝐾2 proteins 1.0 2.5 0.1 200 𝜇 - 0.50 0.25 0.05 20 𝜈 - 1.00 0.20 0.05 20 𝛼 - 0.85 0.02 0.04 20 𝛽 - 5.0 0.5 0.05 50 𝜂 - 1.5 0.2 0.05 20 
Table S3. Summary of the parameters used in the fitting procedure. 
In Fig. S7, we show the inferred distributions for each parameter and in Table S4 
we report first order statistics that describe the inferred values for each fit parameter. 
Parameter Inferences 
Symbol Unit Best Mean std 𝐾" proteins 600 1700 1000 𝐾K proteins 0.052 0.040 0.008 𝐾1 proteins 4.1 2.9 0.7 𝐾34 proteins 8 8 2 𝐾2 proteins 2 8 6 𝜇 - 0.9 0.6 0.2 𝜈 - 1.3 1.5 0.2 𝛼 - 0.85 0.82 0.02 𝛽 - 6.1 6.6 0.7 𝜂 - 1.6 1.8 0.2 
Table S4. Summary of the inferred parameters statistics. 
 
IX. Mathematical analysis of the properties of one-gene and two-gene networks 
In order to investigate the necessary features that can make natural gene 
networks display dosage invariance, we consider a set of genes that are subject to a 
common regulation scheme. The general question that we are interested in addressing 
is: what conditions on the regulation scheme guarantee the activity of the transcriptional 
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center to be invariant to proportional changes in the transcription rate of all the genes 
involved? Such changes would be produced as an organism undergoes a change in 
ploidy, as chromosomes are replicated throughout cell cycle, in genome-wide duplication 
or loss events and/or by global noise in gene expression. 
We consider that each gene is transcribed and then translated proportionally to 
the activity of its transcription center (a number between 0 and 1 that might represent, 
for instance, the fractional occupancy of active promoter sites), the proportionality 
constant being the maximal transcriptional rate associated with the gene. We assume 
that all proteins are effectively degraded at the cell-division rate (𝛾), thinking about a 
situation in which the lifetime of the proteins is much longer than the cell-division time. 
We further consider that proteins generated off each gene interact with each other on 
fast timescales and that this interaction defines the state of the transcriptional center. 
Finally, we consider a mean field approximation in the sense defined in Section VII. 
Under these conditions, we describe the time evolution of the concentrations of 
the relevant proteins by the following set of differential equations: 
⎩⎪⎨
⎪⎧ 𝑑𝑥`𝑑𝑡 = 𝜃`𝑓(𝜌, 𝑥`,⋯ , 𝑥v) − 𝛾𝑥`,⋮d𝑥vd𝑡 = 𝜃v𝑓(𝜌, 𝑥`,⋯ , 𝑥v) − 𝛾𝑥v.f (14)  
In these equations, 𝑥% represents the average total concentration of the protein coded by 
the i-th gene, 𝜃% is the transcriptional strength associated with it, 𝛾 is the dilution rate, 𝜌 
is some external control parameter (e.g., galactose in the case of GAL network) and 𝑓(𝜌, 𝑥`,⋯ , 𝑥v)  is a dimensionless quantity that takes values in [0, 1] and represents the 
activity level of the transcriptional system under consideration. We can think that 𝑓 
represents the fraction of active promoter sites. Under the context of this framework, one 
approach to formalize the question we are interested in addressing is to ask: what family 
of functions 𝑓  describe systems in which the steady state value of 𝑓  is invariant to 
proportional changes in all the 𝜃s  for a wide range of the control parameter 𝜌  (i.e., 
exploring the full range of values of 𝑓, so as to get an inducible system). 
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 One-dimensional case 
Let's first consider the simplest possible case: a network with just one gene. At 
steady state, we have 𝜃𝑓(𝜌, 𝑥) = 𝛾𝑥. (15)  
Mathematically, in order for a function to be invariant with respect to a variable, 
its derivative with respect to that variable has to be zero. Taking the derivative of the 
above expression with respect to 𝜃 we get 
𝑓 + 𝜃 ∂𝑓∂𝑥 d𝑥d𝜃 = 𝛾 d𝑥d𝜃 (16)  
from where we obtain that d{dh = ∂{∂B dBdh = {∂|∂}jMh∂|∂}. 
We conclude that for the system to be invariant for nontrivial fractions (𝑓 ≠ 0) we 
need ∂{∂B = 0 at the value of 𝑥 that solves the steady state equation. But if the system is to 
be inducible, we should assume that the value of 𝑥 will change as we change 𝜌 and 
therefore in order to get invariance across a range of induction conditions we need 𝑓 to 
be independent of 𝑥, i.e., we cannot have feedback at all. 
This means that the only possible way of getting an invariant system with just 
one species is if the system is not autoregulated, which makes the situation trivial: if the 
state of a promoter is not affected by the proteins it codes for, its fractional occupancy 
will be invariant to changes in its transcriptional strength. This situation corresponds to 
the case of a constitutively regulated gene. Having more copies of that gene in the cell is 
not expected to impose any change in the state of its constitutive promoter. 
 
 Two-dimensional case 
Now we consider a network composed of two genes. The system under 
consideration is represented by the following set of differential equations: 
𝑑𝑥`𝑑𝑡 = 𝜃`𝑓(𝜌, 𝑥`, 𝑥") − 𝛾𝑥`,d𝑥"d𝑡 = 𝜃"𝑓(𝜌, 𝑥`, 𝑥") − 𝛾𝑥".f (17)  
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and we are interested in studying how the steady state value of 𝑓 will be affected by 
proportional changes in 𝜃` and 𝜃". 
Let's first note that using the same regulation scheme for the two genes imposes 
the condition that at steady state we must have (all variables represent steady state 
values from now on) 𝜃`𝜃" = 𝑥`𝑥" (18)  
which implies that whatever change 𝑥` might undergo, 𝑥" is going to suffer a proportional 
modification as well. To study system behavior with respect proportional changes in 𝜃` 
and 𝜃", we introduce an additional parameter (𝛿) in the following way: (1 + 𝛿)𝜃`𝑓(𝜌, 𝑥`, 𝑥") = 𝛾𝑥`,(1 + 𝛿)𝜃"𝑓(𝜌, 𝑥`, 𝑥") = 𝛾𝑥",f (19)  
which allows us to vary the transcriptional rates in a proportional manner and to explore 
how the value of 𝑓 is affected by such changes. 
Taking derivatives of both sides of the first equation in (19) with respect to 𝛿, we 
obtain 
𝜃`𝑓 + (1 + 𝛿)𝜃`  ∂𝑓∂𝑥` d𝑥`d𝛿 + ∂𝑓∂𝑥" d𝑥"d𝛿  = 𝛾 d𝑥`d𝛿 . (20)  
Using equation (18) relating 𝑥` to 𝑥" at steady state, we can write dBQd = hQh dBd  and 
plugging this expression into (20) we can solve the resulting equation for dBd :    d𝑥`d𝛿 = 𝜃`𝑓𝛾 − (1 + 𝛿) 7𝜃` ∂𝑓∂𝑥` + 𝜃" ∂𝑓∂𝑥": (21)  
where everything is evaluated at steady state. This implies that the change in 𝑓 due to 
some small change in 𝛿 is proportional to 
d𝑓d𝛿 = 7𝜃` ∂𝑓∂𝑥` + 𝜃" ∂𝑓∂𝑥": 𝑓𝛾 − (1 + 𝛿) 7𝜃` ∂𝑓∂𝑥` + 𝜃" ∂𝑓∂𝑥":. (22)  
We conclude that for the system to be invariant with generality we need to satisfy 
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𝜃` ∂𝑓∂𝑥` + 𝜃" ∂𝑓∂𝑥" = 0 (23)  
at steady state, but this implies that the signs of ∂{∂B and ∂{∂BQ have to be different; i.e., we 
need one activator and one inhibitor. 
Therefore, a gene circuit with two components that are regulated by the same 
transcriptional machinery requires components of opposite sign for the activity of the 
system to be invariant to network dosage. Contrary to the one-dimensional case, the 
genes here do not have to give up their feedback regulation schemes. This describes a 
minimal condition necessary to build dosage-invariant phenotypes into gene networks. In 
the main body of the paper we discuss additional requirements related to the topology of 
the underlying network and the effective stoichiometry of intermediate interactions. 
 
Analysis of alternative two-dimensional topologies 
As described in the main text, to further explore if certain wiring topologies of 
generic 2-component generic networks would make it easier or harder for cells to display 
network dosage invariance, we performed numerical investigations on the possible 
network topologies in which an activator and an inhibitor are controlled by similar 
transcriptional machineries and analyzed their inducibility properties.  
In order to do so we computed numerical approximations to the dynamical 
system representing the evolution of the overall concentrations of activator (𝑎 ) and 
inhibiting (𝑖) agents for systems with different regulation schemes. i.e. we numerically 
solved the equations 
?̇? = 𝜃[𝜆 + (1 − 𝜆)𝑓(𝑔, 𝑎, 𝑖)] − 𝛾𝑎𝚤̇ = 𝜃%[𝜆 + (1 − 𝜆)𝑓(𝑔, 𝑎, 𝑖)] − 𝛾𝑖 f (24)  
over a time interval of 𝑡 = 24 h and computed the value of 𝑓 corresponding to the values 
of 𝑎 and 𝑖 achieved at that point. In these equations the functional form of 𝑓 quantifies 
the regulation scheme of the system. We considered the possibilities described in Fig. 
4A, in each of which the function 𝑓 is parameterized by 4 numbers that quantify the scale 
of action of the activator (𝑆), the scale of action of the inhibitor (𝑆%), the nonlinearity with 
which the activator acts on downstream targets (𝛼) and a corresponding parameter for 
the inhibitor (𝛽). The parameter 𝑔 in these equations represents the concentration of an 
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external activator of the system and, in analogy to how galactose affects the GAL 
system in yeast, we introduced its effect by the effective rescaling of the scale of action 
of the activator. We note that in the chosen parameterization this value is a 
dimensionless quantity. In the case of the network topology presented in the center 
column of Fig. 4, under some conditions this procedure yielded multiple solutions and we 
averaged them across ten random initial conditions (𝑎4, 𝑖4) distributed uniformly across a 
range of values enclosing the possible physiological steady states that 𝑎 and 𝑖  could 
attain (𝑎4 ∈ [0, 𝜃/𝛾], 𝑖4 ∈ [0, 𝜃%/𝛾]) to obtain a mean inducibility level for each galactose 
concentration. 
To investigate which of these systems had the property of both network dosage 
invariance and inducibility we randomly sampled the parameters characterizing the 
regulating functional forms over large ranges (Table S5) and fed them into the 
quantitative model to obtain numerical inducibility curves corresponding to the networks 
carrying one or two copies of the network genes. For each pair of these numerical 
curves, we calculated the level of dosage invariance by quantifying the area between the 
two curves, large areas corresponding to large penalties to network-dosage invariance, 
and vice versa. We also quantified the relative inducibility levels of our numerical curves 
relative to a reference induction profile (Fig. S8A). Large differences from the reference 
curve corresponded to large penalties to inducibility. A comparative examination of the 
dot-plots for each network configuration reveals that the topologies at left and right allow 
their host networks to be both dosage-invariant and inducible (Fig. 4B). The specific 
interaction scheme in the two networks is essential for the systems to display such 
behavior (Fig. 4A, left and right panels). However, the choice between activator and 
inhibitor in directly influencing the transcription is not essential as long as the effect of 
the other is indirect.  
Sampled parameters  Fixed parameters 
Parameter Sampling Lower bound Upper bound Parameter Value 𝑆 logarithmic 10-2 102 𝜃 1500 𝑆% logarithmic 10-3 101 𝜃% 1500 𝛼 linear 0.5 5 𝛾 0.46 𝛽 linear 0.5 5 𝜆 0.2 
Table S5. Parameters used for sampling generic two-component functional forms. 
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The green areas in Fig. 4B enclose the parameters corresponding to dosage-
invariant and inducible networks (low penalties in both axes). For each point populating 
the green regions, we extracted out the values of the set of 4 parameters (Fig. S8B, 
S8C). The parameter that quantifies the nonlinearity of the interaction between the 
inhibiting and activating agents (𝛼 in Fig. 4C and 𝛽 in Fig. 4D) was the only one severely 
restricted in the values it could take; with values displaying a narrow distribution 
centered around 1. This finding suggests a further requirement on the network 
architecture: the effective stoichiometry of the interaction between the activating and 
inhibiting agents has to be 1-to-1 in order to produce a system that is both inducible and 
network-dosage invariant. 
            To further understand the stoichoimetry requirement, it proves useful to look at 
how the functional form in the left panel of Fig. 4A becomes compensated for parallel 
changes in 𝑎 and 𝑖 when  equals 1. In this case the functional form reduces to 
𝑓 = 11 +  𝑆%𝑖1 + 𝑆𝑔𝑎G. (25)  
In the limit 𝑆𝑔𝑎 ≫ 1, which we can interpret as identifying a situation with a 
sufficient amount of activator, we are allowed to make the approximation 
𝑓 ≅ 11 +  𝑆%𝑖𝑆𝑔𝑎G. (26)  
Let’s recall that for values of 𝜆 of order 1, 𝑎 is typically of order 𝜃/𝛾 and so the condition 
above can also be expressed in terms of just parameters of the system as 𝑔 ≫ jh. 
Let’s  now note that in steady state, the ratio between the overall levels of the 
inhibitor and activator is fixed to be 𝑖/𝑎 = 𝜃%/𝜃 as both players are regulated by the 
same scheme (see equation (18)). Therefore we obtain the simple relationship 
𝑓 ≅ 11 +  𝑆%𝑆𝑔 𝜃%𝜃G. (27)  
and we can see that the value of 𝑓 only depends on the ratio of the transcriptional 
strengths, i.e. the system is network dosage invariant. We further note that the system is 
inducible as it is still fully dependent on 𝑔, with potential for achieving the full dynamic 
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range of 𝑓. In other words by changing the value of 𝑔 it is possible to explore values of 𝑓 
in the full range between 0 and 1. This expression also reveals the typical scale at which 
the external inducer has a significant effect on the state of the system: 
𝑓 ≅ 11 + 𝑔typ𝑔 G  with 𝑔typ = 𝑆%𝑆 𝜃%𝜃. (28)  
In Fig. S8D we show how this restriction appears in the numerical exploration we 
performed, by showing the distribution of 𝑔typ over the points that belong to the green 
regions in Fig. 4B. We note that the distribution is centered close to the midpoint of the 
curve used as a reference to quantify inducibility (Fig. S8A). 
Finally we would like to point out that the condition expressed by equation (23) is 
satisfied by any function of the form 𝑓 = 𝑓(𝑔, 𝑥`/𝑥"), i.e. any function that depends on 
the concentration of the two relevant players through their ratio. This allows one to 
understand why the regulation schemes depicted at the left and at the right of Fig. 4A 
can be both inducible and network-dosage invariant and why the system in the center 
does not have this property. In the case in which the regulation is such that the activator 
and the inhibitor act independently of each other the only way in which such a 
dependence on the ratio of the concentrations can be achieved is if  𝑆𝑔𝑎 ≪ 1, 𝑆%𝑖 ≫ 1 
and 𝛼 = 𝛽, which yields 
𝑓 ≅ 𝑆𝑔𝑎𝑆%𝑖 G. (29)  
We can see how in this limit even though the system would be network dosage invariant 
it can not be fully inducible as this approximation can not be valid for large values of 𝑔, 
as that would yield unphysical values for 𝑓. 
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SUPPLEMENTARY FIGURE CAPTIONS 
 
Fig. S1. Construction scheme of the first-order dosage-varied yeast strains. Each 
rectangle denotes a diploid strain that was dosage-halved in one of the four regulatory 
genes of the network. 
 
Fig. S2. Measurements of the network inducibility level as a function of galactose 
concentration for all the different strains analyzed. Inducibility is quantified as the 
fraction of ON-cells in a bimodal population. The genetic background of each strain is 
specified by a square on the upper left corner. Each big square contains four small 
squares that represent the four regulatory genes of the GAL network (top-left: GAL2, 
top-right: GAL3, bottom-left: GAL4, bottom-right: GAL80). Grey (white) color marks the 
presence of two (one) copies of a specific gene. A line between two strains indicates that 
the two genetic backgrounds differ by a single copy of a specific gene and the color of 
the line codifies that gene (blue for GAL3, red for GAL80, green for GAL2, and orange 
for GAL4). In all cases except for the wild type, the measurements that correspond to the 
wild type were included as a reference (gray trace). The strongest second-order 
compensation was observed when both GAL3 and GAL80 were dosage-perturbed in the 
same strain. At the third-order, irrespective of the second-order genetic background on 
which the dosage of a third gene was reduced, halving the dosage of GAL3 (GAL80) 
always decreased (increased) the inducibility levels. On the other hand, varying the 
dosage of GAL2 had a neutral effect on inducibility and halving the dosage of GAL4 
decreased it slightly. 
 
Fig. S3. Quantification of the effect of each gene. (A) Contribution of the second copy 
of each regulatory gene to network inducibility quantified as the squared difference (𝜒") 
between inducibility levels in strains that differ in one copy of the corresponding gene, 
averaged across different galactose concentrations and genetic backgrounds. (B) 
Signed contribution of the second copy of each regulatory gene to network inducibility 
quantified as the signed difference (∆) between inducibility levels in strains that differ in 
one copy of the corresponding gene, averaged across different galactose concentrations 
and genetic backgrounds. Fig. S3B is the same as Fig. 3C and it is included here for 
reference purposes. 
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Fig. S4. The genetic switch between the OFF and ON states of the GAL network. 
ON-cells express (blue dotted arrows) both the positive (Gal2p and Gal3p) and the 
negative (Gal80p) regulators of the network while the OFF-cells’ gene expression does 
not exceed basal levels. Gal4p is a constitutively expressed protein. Red arrows with 
pointed and blunted ends reflect the positive and negative effect of one network 
component on another, respectively. 
 
Fig. S5. Stochastic simulations of the proposed model. (A-F) Left subpanels: traces 
of the different variables (number of promoter in an ON state, PGALiON, and protein 
concentrations, galip) corresponding to one realization of the stochastic model proposed 
in Section V for a time of 24 h. Right subpanels: Distribution of the different variables 
after 24 h (left) and 48 h (right) across 100 independent realizations. The fact that these 
distributions are similar to each other indicates that the process has reached a steady 
state. In all cases, simulations were started from initial conditions that correspond to an 
OFF state, namely, all promoters were OFF initially and the initial protein concentrations 
were chosen as 𝜃%𝜆/𝛾  for GAL2, GAL3 and GAL80 and as 𝜃2/𝛾  for GAL4. The 
parameters used were those indicated in Sections VI and VIII and the value of ℎ used in 
this set of simulations was ℎ ≅ 2.5 h-1. 
 
Fig. S6. Effect of 𝒉  and comparison between stochastic simulations and the 
proposed analytical approximation. (A-C) Simulations similar to those described in 
fig. S5 but for a fixed galactose concentration of 0.1% w/v and for three different values 
of ℎ. (D) Fraction of ON cells according to the analytical approximation (solid line) and 
the stochastic simulations (dots). In the case of the stochastic simulations, the fraction of 
ON cells was determined by dividing the GAL3 expression profile to two regions 
separated by the gray line (fig. S5, fig. S6A-C, right subpanels) and counting the fraction 
of cells in the region that corresponds to higher expression levels. The gray line lies 
exactly in between the maximal and basal expression levels. Blue dots are the fractions 
obtained from 100 simulations at 24 h and the gray dots correspond to the results at  
48 h. 
 
Fig. S7. Inferences on the parameters that best describe the data. Metropolis-
Hastings samples of the parameter values that best describe the data, according to a 
Bayesian-inference approach (see Section VIII).  
22 
 
 
Fig. S8. Numerical exploration of network dosage invariance and inducibility in 
two-component systems. (A) Inducibility curve used as a reference for the numerical 
exploration described in the last part of Section IX. (B, C) Histograms of the parameter 
values corresponding to the green regions shown in Fig. 4B for the left (B) and right (C) 
configurations described in Fig. 4A. The dotted lines show what one would expect if the 
parameters had no effect in determining whether the system was in the green region or 
not (uniform distributions over the sampled values). (D) Distribution of the ratio 𝑔typ =ll for the points in the green regions shown in Fig. 4B. 
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